openPR Logo
Press release

Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Huge Growth Opportunities and Trends to 2026 | Siemens Healthineers, Biopredictive, Quest Diagnostics

06-04-2021 02:40 PM CET | Health & Medicine

Press release from: Market Insights Reports

The Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Perspective, Comprehensive Analysis, and Major Segments and Forecast, 2021-2026. The Non-alcoholic Steatohepatitis (NASH) Biomarkers market report is a valuable source of data for business strategists. It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; cost, revenue, demands, and supply data (as applicable). The report explores the current outlook in global and key regions from the perspective of players, countries, product types, and end industries. This Non-alcoholic Steatohepatitis (NASH) Biomarkers study provides comprehensive data that enhances this report's understanding, scope, and application.

Top Companies in the Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market:
Biopredictive, Quest Diagnostics, Exalenz Bioscience, GENFIT, Siemens Healthineers, ONE WAY LIVER, Prometheus Laboratories, Gilead Sciences, among others.

Over the next five years the Non-alcoholic Steatohepatitis (NASH) Biomarkers market will register a 31.4% CAGR in terms of revenue, the global market size will reach US$ 2930.7 Billion by 2026.

Market Overview
Non-alcoholic steatohepatitis (NASH), is a common liver disease, often called as silent liver disease. It is asymptomatic until its later stages, and thus many patients are unaware of their condition. As the treatment cycle of NASH is long, routine monitoring regarding the progress of the treatment is crucial, demanding use of methods such as liver biopsies.

Get Free Sample PDF Copy of Latest Research on Non-alcoholic Steatohepatitis (NASH) Biomarkers Market 2020 Before the purchase
https://www.marketinsightsreports.com/reports/04192810246/global-non-alcoholic-steatohepatitis-nash-biomarkers-market-growth-2021-2026/inquiry?Source=openpr&Mode=46

Market Insights
The incidence of NASH (Non-alcoholic Steatohepatitis) has progressed over time, and it usually leads to liver failure. Twenty percent of patients suffering from this disease are prone to cirrhosis-a condition wherein healthy tissues are replaced with scar tissues-and 10% succumb to death. According to estimates by the United States Census Bureau in 2009, people older than 65 represented around 13% of the total population in the U.S., and this is expected to grow to an estimated 20% by 2030.

Competitive Landscape
-Quest Diagnostics made a partnership with Houston Healthcare to improve the delivery services of the laboratory in 2018. They are expected to boost their position with this partnership in the upcoming years
-Prometheus launched the FIBROSpect NASH test in 2017 October to help the NASH patients get better services based on liver fibrosis severity. The company is expecting to catch up to a higher position in the market with the introduction of this test.
In 2018 November, Siemens Healthineers announced the approval of the RLF test breakthrough from the FDA. It is intended to help the patients get more effective and time-efficient diagnoses to get better treatment from the life-threatening disease.

This report segments the global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market based on Types are:
Serum Biomarkers
Cytokeratin-18 (CK 18) Marker
Inflammatory Markers
Others

Based on Application, the Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market is Segmented into:
Hospitals
Diagnostic Centers
Others

Inquire for Discount
https://www.marketinsightsreports.com/reports/04192810246/global-non-alcoholic-steatohepatitis-nash-biomarkers-market-growth-2021-2026/discount?Source=openpr&Mode=46

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), and market share and growth rate of Non-alcoholic Steatohepatitis (NASH) Biomarkers Market these regions, from 2020 to 2026 (forecast), covering
North America, Europe, China, Japan, Southeast Asia, India, North America (USA, Canada, and Mexico) Europe (Germany, France, UK, Russia, and Italy) Asia-Pacific (China, Japan, Korea, India, and Southeast Asia) South America (Brazil, Argentina, Columbia, etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa).

Impact of the Non-alcoholic Steatohepatitis (NASH) Biomarkers market report:
– A comprehensive evaluation of all opportunities and risks in the market.
– Non-alcoholic Steatohepatitis (NASH) Biomarkers market ongoing developments and significant occasions.
– A detailed study of business techniques for the development of the market-driving players.
– Conclusive study about the improvement plot of the Non-alcoholic Steatohepatitis (NASH) Biomarkers market for approaching years.
– Top to the bottom appreciation of market-express drivers, targets, and major littler scale markets.
–Favourable impressions inside imperative mechanical and publicize the latest examples striking the market.

What are the Non-alcoholic Steatohepatitis (NASH) Biomarkers market factors that are explained in the report?
-Key Strategic Developments: The study also includes the key strategic developments of the Non-alcoholic Steatohepatitis (NASH) Biomarkers market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a global and regional scale.

-Key Market Features: The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. Also, the study offers a comprehensive study of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments.

–Analytical Tools: The Global Digital Rights Management Market report includes the accurately studied and assessed data of the key industry players and their scope in the market utilizing several analytical tools. Analytical tools such as Porter’s five forces analysis, SWOT analysis, feasibility study, and investment return analysis have been used to analyze the key players' growth in the market.

The report has 150 tables and figures browse the report description and TOC
https://www.marketinsightsreports.com/reports/04192810246/global-non-alcoholic-steatohepatitis-nash-biomarkers-market-growth-2021-2026?Source=openpr&Mode=46

We can also provide the following additional customization and information at an additional cost and delivery time:
1- A detailed country wise market share analysis of the various companies and their brands.
2- We can also provide country wise analysis of the market for more specific market segments.
3- We can also provide a detailed pipeline report for the devices and related drugs for better understanding of the market.

Please Note: All the above points come under additional customization and the costs can be confirmed with our sales team : sales@marketinsightsreports.com

Related reports
Global Serum Biomarkers Market Research Report 2021
https://www.marketinsightsreports.com/reports/02042586508/global-serum-biomarkers-market-research-report-2021?Mode=46

Global Nash Drugs Market Research Report With Opportunities And Strategies To Boost Growth- COVID-19 Impact And Recovery
https://www.marketinsightsreports.com/reports/01122533348/global-nash-drugs-market-research-report-with-opportunities-and-strategies-to-boost-growth-covid-19-impact-and-recovery?Mode=46

All the reports that we list have been tracking the impact of COVID-19. Both upstream and downstream of the entire supply chain have been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check with the sales team.

Contact Us:
Irfan Tamboli (Sales Manager) - Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

ABOUT US
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology, and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Huge Growth Opportunities and Trends to 2026 | Siemens Healthineers, Biopredictive, Quest Diagnostics here

News-ID: 2298659 • Views:

More Releases from Market Insights Reports

Cold Chain Monitoring Market May See a Big Move | BlueAir, Denso, Eureka Forbes, Honeywell
Cold Chain Monitoring Market May See a Big Move | BlueAir, Denso, Eureka Forbes, …
Market Insights Reports published a new research publication on "Cold Chain Monitoring Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Cold Chain Monitoring market was mainly driven by the increasing R&D spending across the world. Some of the key players
Outbound Logistics Market Next Big Thing | Major Giants- Draexlmaier, Faurecia, Grupo Antolin
Outbound Logistics Market Next Big Thing | Major Giants- Draexlmaier, Faurecia, …
Market Insights Reports published a new research publication on "Outbound Logistics Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Outbound Logistics market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled in
Veterinary Telemedicine Market May See a Big Move | Nestle, Deuerer, The J.M. Smucker
Veterinary Telemedicine Market May See a Big Move | Nestle, Deuerer, The J.M. Sm …
Market Insights Reports published a new research publication on "Veterinary Telemedicine Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Veterinary Telemedicine market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled in
Precision Planting Market is Set to Fly High in Years to Come
Precision Planting Market is Set to Fly High in Years to Come
Market Insights Reports published a new research publication on "Precision Planting Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Precision Planting market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled in

All 5 Releases


More Releases for NASH

Nonalcoholic Steatohepatitis (NASH) Market Massive Growth opportunity Ahead
Introduction Nonalcoholic Steatohepatitis (NASH) is an advanced form of nonalcoholic fatty liver disease (NAFLD) characterized by fat accumulation in the liver along with inflammation and liver cell damage. If left untreated, NASH can progress to fibrosis, cirrhosis, liver failure, or hepatocellular carcinoma. Closely tied to the global obesity and diabetes epidemic, NASH has become a major healthcare burden, with millions affected worldwide and no widely approved curative therapy to date. The NASH
Non-Alcoholic Steatohepatitis (NASH) - Drug Pipeline Landscape, 2023
Nonalcoholic steatohepatitis (NASH) is a type of fatty liver disease. It is characterized by the accumulation of fat in the liver, inflammation, and damage. NASH can lead to cirrhosis, liver failure, and death. The exact cause of NASH is unknown, but it is believed to be associated with obesity, insulin resistance, and diabetes. Treatment of NASH is focused on weight loss, exercise, and the control of diabetes and insulin resistance. NASH
Non Alcoholic Steatohepatitis (NASH) Market Size to Hit $21,879 Million by 2028 …
According to our experience research team, Non Alcoholic Steatohepatitis (NASH) Market was valued at USD 1,569 Million in 2021, and the global Non Alcoholic Steatohepatitis (NASH) industry is projected to reach a value of USD 21,879 Million by 2028, at a CAGR of 60.4% during the forecast period 2022-2028 The report is focused on gaining various Non Alcoholic Steatohepatitis (NASH) market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining
NASH Market Insight and Landscape report
Report Snapshot: NASH is one of the furthermost causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming years, with the disease affecting both adults and children. The epidemiology and demographic characteristics of NASH vary across different country level. Furthermore, individuals with NAFLD have a high frequency of metabolic comorbidities and could place a growing strain on health-care systems from their
04-07-2017 | Arts & Culture
Memphia PR
Nash releases debut EP 'She Don't Know'
London-based singer/songwriter Nash has released his debut EP She Don’t Know. Recorded at the legendary RAK Studios, She Don’t Know has the feel of 60s rock but with a modern twist, leaving the listener hooked throughout and wanting to come back for another listen. She Don’t Know’s leading single CK is an infectious number which is sure to be a hit for 2017. Listening to the Beatles and Jack White growing
Nash Technologies at GITEX/GULFCOMMS 2010
Harvey Nash subsidiary presents expert services to telecom operators in the Middle East, Africa and South Asia region Nürnberg/Germany, 10th September 2010 – For the first time Nash Technologies will be present at GITEX/GULFCOMMS, the largest international trade event for mobile, fixed, IP and satellite communications for the Middle East, Africa and South Asia region, in Dubai from 17th to 21st October 2010 offering its telecom expert services. Nash Technologies will